Skip to content
10-Q

Quarterly Report

MEDICINES CO /DE

0001113481-19-000024

← back to feed
Filed
Jul 24, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Jul 22, 2019 79.35M sh
Shares Diluted Q2 2019 · Jun 30, 2019 74.81M sh
Shares Diluted Q2 2019 · Jun 30, 2019 74.23M sh
Shares Diluted Q2 2019 · Jun 30, 2018 73.35M sh
Shares Diluted Q2 2019 · Jun 30, 2018 73.57M sh
Capex Q2 2019 · Jun 30, 2019 $0
Capex Q2 2019 · Jun 30, 2018 $7K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$98.6M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$165.34M
Short Term Investments Q2 2019 · Jun 30, 2019 $4.41M
Short Term Investments Q2 2019 · Dec 31, 2018 $2.63M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $319.27M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $238.31M
Cash And Equivalents Q2 2019 · Jun 30, 2018 $162.53M
Stockholders Equity Q2 2019 · Jun 30, 2019 $38.13M
Stockholders Equity Q2 2019 · Mar 31, 2019 −$75.39M
Stockholders Equity Q2 2019 · Dec 31, 2018 −$22.26M
Stockholders Equity Q2 2019 · Jun 30, 2018 $21.23M
Stockholders Equity Q2 2019 · Mar 31, 2018 $67.66M
Stockholders Equity Q2 2019 · Dec 31, 2017 $24.91M
Current Liabilities Q2 2019 · Jun 30, 2019 $63.96M
Current Liabilities Q2 2019 · Dec 31, 2018 $58.41M
Total Liabilities Q2 2019 · Jun 30, 2019 $918.14M
Total Liabilities Q2 2019 · Dec 31, 2018 $863.95M
Current Assets Q2 2019 · Jun 30, 2019 $381.63M
Current Assets Q2 2019 · Dec 31, 2018 $294.8M
Total Assets Q2 2019 · Jun 30, 2019 $956.27M
Total Assets Q2 2019 · Dec 31, 2018 $841.69M
Eps Diluted Q2 2019 · Jun 30, 2019 −$0.80
Eps Diluted Q2 2019 · Jun 30, 2019 −$1.62
Eps Diluted Q2 2019 · Jun 30, 2018 −$0.74
Eps Diluted Q2 2019 · Jun 30, 2018 −$0.34
Eps Basic Q2 2019 · Jun 30, 2019 −$0.80
Eps Basic Q2 2019 · Jun 30, 2019 −$1.62
Eps Basic Q2 2019 · Jun 30, 2018 −$0.74
Eps Basic Q2 2019 · Jun 30, 2018 −$0.34
Sga Expense Q2 2019 · Jun 30, 2019 $19.89M
Sga Expense Q2 2019 · Jun 30, 2019 $36.87M
Sga Expense Q2 2019 · Jun 30, 2018 $21.01M
Sga Expense Q2 2019 · Jun 30, 2018 $49.96M
Rd Expense Q2 2019 · Jun 30, 2019 $28.11M
Rd Expense Q2 2019 · Jun 30, 2019 $55.12M
Rd Expense Q2 2019 · Jun 30, 2018 $30.29M
Rd Expense Q2 2019 · Jun 30, 2018 $70.66M
Net Income Q2 2019 · Jun 30, 2019 −$60.06M
Net Income Q2 2019 · Jun 30, 2019 −$119.92M
Net Income Q2 2019 · Mar 31, 2019 −$59.87M
Net Income Q2 2019 · Jun 30, 2018 −$54.2M
Net Income Q2 2019 · Jun 30, 2018 −$25.05M
Net Income Q2 2019 · Mar 31, 2018 $29.15M
Operating Income Q2 2019 · Jun 30, 2019 −$48M
Operating Income Q2 2019 · Jun 30, 2019 −$91.99M
Operating Income Q2 2019 · Jun 30, 2018 −$52.57M
Operating Income Q2 2019 · Jun 30, 2018 −$116.85M
Cost Of Revenue Q2 2019 · Jun 30, 2019 $0
Cost Of Revenue Q2 2019 · Jun 30, 2019 $0
Cost Of Revenue Q2 2019 · Jun 30, 2018 $2.93M
Cost Of Revenue Q2 2019 · Jun 30, 2018 $5.67M
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2018 $1.67M
Revenue Q2 2019 · Jun 30, 2018 $9.44M